Acorda Therapeutics plummets as much as 13% on failed trial, discontinued drug development
November 21, 2016 at 09:25 AM EST
The latest results for a post-stroke walking difficulties drug weren’t clinically meaningful.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.